BiotechTube

I-DXd + Rescue Medication

Phase 1/2Recruiting
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Oesophageal Squamous Cell Carcinoma

Conditions

Oesophageal Squamous Cell Carcinoma

Trial Timeline

Mar 11, 2026 → Jun 12, 2028

NCT ID
NCT07405151

About I-DXd + Rescue Medication

I-DXd + Rescue Medication is a phase 1/2 stage product being developed by Daiichi Sankyo for Oesophageal Squamous Cell Carcinoma. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07405151. Target conditions include Oesophageal Squamous Cell Carcinoma.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT07405151Phase 1/2Recruiting

Competing Products

20 competing products in Oesophageal Squamous Cell Carcinoma

See all competitors
ProductCompanyStageHype Score
Ramucirumab + Paclitaxel + PlaceboEli LillyPhase 3
77
Ramucirumab + Paclitaxel + Sacituzumab Tirumotecan + Rescue Medications + HER3-DXdDaiichi SankyoPhase 1/2
41
Trastuzumab DeruxtecanDaiichi SankyoPhase 2
52
zolbetuximabAstellas PharmaPre-clinical
23
zolbetuximab + placebo + oxaliplatin + folinic acid + fluorouracilAstellas PharmaPhase 3
77
zolbetuximabAstellas PharmaPre-clinical
23
epirubicin + oxaliplatin + capecitabine + zolbetuximabAstellas PharmaPhase 2
52
zolbetuximab + oxaliplatin + capecitabine + placeboAstellas PharmaPhase 3
77
FamotidineAstellas PharmaPhase 2/3
65
zolbetuximab + Pembrolizumab + Capecitabine + Oxaliplatin + Folinic acid (leucovorin or local equivalent) + 5-fluorouracil (5-FU) + PlaceboAstellas PharmaPhase 3
77
Gentuximab + PaclitaxelSun PharmaceuticalPhase 1/2
41
E3810 + E3810 + PlaceboEisaiPhase 3
77
Rabeprazole ER + RanitidineEisaiPhase 3
77
E3710 + E3710EisaiPhase 1
33
rabeprazole and pantoprazoleEisaiApproved
85
Rabeprazole 20 mgEisaiPhase 2
52
rabeprazole sodiumEisaiPhase 2
52
RABEPRAZOLE SODIUM + RABEPRAZOLE SODIUMEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
rabeprazole sodium + PlaceboEisaiPhase 3
77

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85